C71T
CANCELLED SECTION 71
06/03/2026
Voltar para busca
Dado oficial do USPTO
HDATA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
31/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
12/06/2014
Data de registro
18/08/2015
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/03/2026
Última transação
31/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
LEIPZIG, MARC J
Unidade examinadora
M60
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
HVIVO SERVICES LIMITED
Retroscreen Virology Limited
Representantes
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business investigation and research services relating to cost and business efficiencyall relating to pharmaceuticalsmedicinemedicinesvaccinessciencebacteriologytoxicologychemistryclinicologyoncologybiochemistry and biotechnology; systemisation and compilation of medical information into computer databases; providing statistical information for business purposesall of said information relating to pharmaceuticalsmedicinemedicinesvaccinessciencebacteriologytoxicologychemistryclinicologyoncologybiochemistry and biotechnology; services consisting of the registrationcollectiontranscriptioncompilation and systemization of written communications and data with respect to diagnostic testing; product demonstration services in the field of diagnostic testing; computerized database management services in the fields of diagnostic testing and preparations for the treatmentmonitoring and diagnosis of disease; trade information services in the fields of medicalhealthclinical care; database management of diagnostic testing and resultsdatabase management of medicalhospitalinsurance and billing records; providing business information for the purpose of providing referral services in the fields of medicalhealth and clinical care; providing business information regarding the results from medical and pharmaceutical diagnostic testing; providing business information regarding medical and pharmaceutical testing procedures; providing business information regarding disease conditions and disease prevention; providing business information regarding medicalhospitalinsurance and billing records
Classe 42
Medical research services; scientific research in the nature of conducting clinical trials; medical research laboratory services; medical research laboratory services for the analysis of samples taken from patients; scientific research; product development relating to pharmaceuticalsmedicinesmedicaments and veterinary products; medical research servicesclinical testing servicesphysician testing services for assisting pharmacistspharmaceutical testing servicesmedical laboratory and testing services; medical research into the causes and treatment of influenza and the common cold
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
18/08/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/07/2024
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
13/06/2022
71AG
REGISTERED-SEC.71 ACCEPTED
13/06/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/06/2022
ES71
TEAS SECTION 71 RECEIVED
28/12/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
18/08/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/05/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
20/02/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/02/2016
FIMP
FINAL DISPOSITION PROCESSED
03/02/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
18/11/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
18/08/2015
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
24/07/2015
GPNX
NOTIFICATION PROCESSED BY IB
27/06/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/06/2015
PUBO
PUBLISHED FOR OPPOSITION
02/06/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/05/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
13/05/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/05/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
27/04/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/04/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/04/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/04/2015
ALIE
ASSIGNED TO LIE
15/04/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/04/2015
RFNT
REFUSAL PROCESSED BY IB
31/01/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/01/2015
RFRR
REFUSAL PROCESSED BY MPU
09/01/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/01/2015
CNRT
NON-FINAL ACTION WRITTEN
04/01/2015
MAFR
APPLICATION FILING RECEIPT MAILED
03/01/2015
DOCK
ASSIGNED TO EXAMINER
30/12/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/12/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/12/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HDATA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.